Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - ACCOUNTS PAYABLE
Accounts Payable DNLI - Denali Therapeutics Inc.
9.48 M
LAST VALUE
40.87%
2 YEAR CAGR
38.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR